company background image
1099

Sinopharm Group SEHK:1099 Stock Report

Last Price

HK$19.68

Market Cap

HK$61.4b

7D

-0.2%

1Y

9.0%

Updated

04 Feb, 2023

Data

Company Financials +

1099 Stock Overview

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China.

1099 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health4/6
Dividends5/6

Rewards

Trading at 93.4% below our estimate of its fair value

Earnings are forecast to grow 3.77% per year

Pays a reliable dividend of 4.41%

Risk Analysis

No risks detected for 1099 from our risk checks.

My Notes

New

Notes are coming soon

Sinopharm Group Co. Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sinopharm Group
Historical stock prices
Current Share PriceHK$19.68
52 Week HighHK$21.35
52 Week LowHK$14.60
Beta0.76
1 Month Change-4.00%
3 Month Change28.13%
1 Year Change8.97%
3 Year Change-25.45%
5 Year Change-38.60%
Change since IPO6.26%

Recent News & Updates

Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Jan 19
Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Is Sinopharm Group (HKG:1099) A Risky Investment?

Nov 18
Is Sinopharm Group (HKG:1099) A Risky Investment?

Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Oct 03
Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Recent updates

Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Jan 19
Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Is Sinopharm Group (HKG:1099) A Risky Investment?

Nov 18
Is Sinopharm Group (HKG:1099) A Risky Investment?

Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Oct 03
Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jul 31
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Jul 10
Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

Jun 05
Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Apr 11
We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Mar 21
A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Mar 03
Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jan 09
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Dec 19
Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Dec 01
Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Sep 23
These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Sep 10
A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Aug 28
Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Jun 13
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Jun 06
Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

May 24
Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

May 11
Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

Mar 20
Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

Mar 05
We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Feb 18
You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Feb 03
Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?

Jan 19
Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?

At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?

Jan 06
At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?

What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?

Dec 25
What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?

Read This Before Buying Sinopharm Group Co., Ltd. (HKG:1099) Shares

Dec 15
Read This Before Buying Sinopharm Group Co., Ltd. (HKG:1099) Shares

We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Dec 04
We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Sinopharm Group's (HKG:1099) Stock Price Has Reduced 43% In The Past Five Years

Nov 25
Sinopharm Group's (HKG:1099) Stock Price Has Reduced 43% In The Past Five Years

Reflecting on Sinopharm Group's (HKG:1099) Share Price Returns Over The Last Three Years

Aug 22
Reflecting on Sinopharm Group's (HKG:1099) Share Price Returns Over The Last Three Years

Is Weakness In Sinopharm Group Co., Ltd. (HKG:1099) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Aug 10
Is Weakness In Sinopharm Group Co., Ltd. (HKG:1099) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Will Weakness in Sinopharm Group Co., Ltd.'s (HKG:1099) Stock Prove Temporary Given Strong Fundamentals?

Aug 10
Will Weakness in Sinopharm Group Co., Ltd.'s (HKG:1099) Stock Prove Temporary Given Strong Fundamentals?

What To Know Before Buying Sinopharm Group Co., Ltd. (HKG:1099) For Its Dividend

Jul 26
What To Know Before Buying Sinopharm Group Co., Ltd. (HKG:1099) For Its Dividend

Sinopharm Group Co., Ltd.'s (HKG:1099) Business Is Trailing The Market But Its Shares Aren't

Jul 13
Sinopharm Group Co., Ltd.'s (HKG:1099) Business Is Trailing The Market But Its Shares Aren't

How Much Is Sinopharm Group's (HKG:1099) CEO Getting Paid?

Jun 28
How Much Is Sinopharm Group's (HKG:1099) CEO Getting Paid?

Shareholder Returns

1099HK HealthcareHK Market
7D-0.2%0.4%-3.4%
1Y9.0%-44.4%-12.3%

Return vs Industry: 1099 exceeded the Hong Kong Healthcare industry which returned -44.3% over the past year.

Return vs Market: 1099 exceeded the Hong Kong Market which returned -12.3% over the past year.

Price Volatility

Is 1099's price volatile compared to industry and market?
1099 volatility
1099 Average Weekly Movement4.6%
Healthcare Industry Average Movement8.8%
Market Average Movement7.8%
10% most volatile stocks in HK Market15.5%
10% least volatile stocks in HK Market3.8%

Stable Share Price: 1099 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 1099's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003112,859Yong Liuhttps://www.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics.

Sinopharm Group Co. Ltd. Fundamentals Summary

How do Sinopharm Group's earnings and revenue compare to its market cap?
1099 fundamental statistics
Market CapHK$61.41b
Earnings (TTM)HK$9.17b
Revenue (TTM)HK$632.67b

6.7x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1099 income statement (TTM)
RevenueCN¥546.15b
Cost of RevenueCN¥500.52b
Gross ProfitCN¥45.63b
Other ExpensesCN¥37.71b
EarningsCN¥7.91b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)2.54
Gross Margin8.35%
Net Profit Margin1.45%
Debt/Equity Ratio68.4%

How did 1099 perform over the long term?

See historical performance and comparison

Dividends

4.4%

Current Dividend Yield

30%

Payout Ratio